Alzheimer's Risk Reduction Protocol (Bredesen ReCODE)
A multi-part protocol developed by Dr.
40/100
Dale Bredesen
Risk reduction is lifelong; people with early symptoms often reassess after 6 to 12 months
24 phases
3 conditions
Protocol Overview
A multi-part protocol developed by Dr. Dale Bredesen that looks for many possible contributors to cognitive decline (insulin resistance, inflammation, hormones, toxins, sleep) and addresses each one. Used alongside care from a neurologist.
Used For
Key Resources
Safety Profile
Bredesen's view is that Alzheimer's is the end result of many contributors (infections, inflammation, toxins, vascular and metabolic factors, loss of nutrient and hormone support), and his approach targets each one a person has. His published case series and a small 2022 proof-of-concept trial report improvement in some people with early decline, but there is no large controlled trial yet, so evidence is early. Many individual parts are well supported for brain health: exercise, blood sugar control, treating sleep apnea and hearing, and the multidomain FINGER trial showed better cognitive scores with diet, exercise, brain training and vascular care. ApoE4 carriers have higher risk and may benefit most from early action. The approach is used alongside care from a neurologist, including any standard treatments.
Find a Practitioner
Gabriel can find and book a practitioner who works with this approach.
Book with GabrielAbout Evidence Score
The Evidence Score (0 to 100) rates the strength of evidence from studies in people for the uses listed: higher means stronger, more consistent research. It does not measure safety. It is not medical advice.
For education, not medical advice. Talk with a licensed clinician before you start, and never stop or change a prescribed medication without your prescriber.